RFID: Electronic Pharmaceutical Pedigree

A growing number of U.S. states are formalizingthe authentication is actually done off-network,"
electronic pedigree requirements in order tosays Ahlund.
comply with the FDA's anti-counterfeiting"We're using multiple layers of protection," says
initiatives.Graham Gillen, senior product manager for
A new two-phase RFID authentication platformVeriSign. "Ultimately, it's about making the tag, and
introduced by Texas Instruments (TI) andhence the product, hard to fake or reproduce."
VeriSign should make it easier for pharmaceuticalThe platform is non-proprietary and can be
manufacturers, suppliers, distributors andimplemented by any RFID system and PKI
pharmacies to meet the FDA drug pedigreeprovider. That can save drug manufacturers and
requirements. It may also make it easier forsuppliers the considerable infrastructure costs
consumers to accept RFID technology in theirassociated with deploying most RFID systems.
prescription packaging.The additional security may relieve some
Mikael Ahlund, director of RFID healthcare for TI,consumers' fears that their personal and private
says that the platform is unique in providing twoinformation may be intercepted by electronic
layers of protection against counterfeiting. Thehackers.
model enhances system security by digitallyThe idea of using RFID in the prescription drug
certifying the authenticity of 13.56 MHz RFID tagspipeline has had consumers and pharmaceutical
via a cryptographic Public Key Infrastructure (PKI)manufacturers/suppliers hotly at odds. The TI
available through VeriSign. "The beauty of thisVerisign model suggests that when used with
approach is that because the elements for thecare, RFID may indeed be protective without
private key are preprogrammed into the tag andbeing invasive.
the reader is preprogrammed for the public key,